Human study · Supplements / medicine · 6 Oct 2026
In 12 women ages 35 to 60, two weeks of hinoki-root scent at home lined up with fewer night awakenings
Source: Kyushu University / Journal of Wood Science
What the research found
Study (small home crossover; 12 Japanese women ages 35 to 60). ScienceDaily carried the Kyushu University account on 6 October 2026. Fadilla Zennifa, Kuniyoshi Shimizu, and colleagues report in the Journal of Wood Science (2026; doi 10.1186/s10086-026-02296-3). The oil came from roots of hinoki, Chamaecyparis obtusa, a timber tree whose roots are often discarded. Each woman used the oil for two weeks and an unscented control for two weeks, in random order, single-blind. Three drops went into a paper cup; she inhaled for 10 seconds, then left the cup about 30 centimeters from her nose overnight. A headband recorded brain waves and a watch tracked sleep. By day 13, the oil period was linked with feeling less sleepy and more recovered on waking, and the watches showed fewer awakenings. After seven days, delta-wave activity rose around sleep onset. The scent was rated more relaxing than the control. The sample is 12 people. This is not a sleep medicine, and the release does not compare it with treatment for a sleep disorder. Educational notes. This is not medical advice.
Evidence level: Human study. A study in people, but an association isn't proof of cause.
Read the original at Kyushu University / Journal of Wood Science
More supplements / medicine news
- In mice, the experimental drug KCL-286 reduced DNA breaks and brain inflammation in an Alzheimer's model
- In aged rats, two weeks of the experimental drug cinaciguat cut circulating amyloid-beta about in half and brought LDL down to youthful levels
- In 104 people with a sudden retinal-artery blockage, papaverine use lined up with better functional vision in a retrospective comparison
- A Cell Metabolism letter questions whether a fasting GLP-1 level shows how many gut L-cells a person has
- In FDA reports, caffeine and stimulant supplement use was tied to cardiac arrest about 11 times more often, and 45 percent of those cardiovascular reports were ages 18 to 34